Get the Stockscreener App
6.14
6.60%
0.38
After Hours:
6.14
Clene Inc stock is traded at $6.14, with a volume of 42,814.
It is up +6.60% in the last 24 hours and up +6.41% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$5.76
Open:
$5.79
24h Volume:
42,814
Relative Volume:
0.23
Market Cap:
$63.45M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-1.3767
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
+3.02%
1M Performance:
+6.41%
6M Performance:
+57.44%
1Y Performance:
+10.63%
1-Day Range:
$5.71
$6.285
1-Week Range:
$5.54
$6.285
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.14 | 59.52M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 5th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 13,095 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 4,015 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Published on: 2026-01-01 16:53:08 - moha.gov.vn
Nanotechnology Stocks To ResearchDecember 31st - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 8,096 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,138 Shares - MarketBeat
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 6,831 Shares of Stock - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock By Investing.com - Investing.com Nigeria
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 3,350 Shares - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock - Investing.com
Nanotechnology Stocks To Follow TodayDecember 29th - MarketBeat
Short Interest in Clene Inc. (NASDAQ:CLNN) Increases By 47.4% - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Promising Nanotechnology Stocks To Follow NowDecember 22nd - MarketBeat
Promising Nanotechnology Stocks To Keep An Eye OnDecember 25th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnDecember 23rd - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,367 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 5,582 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Promising Nanotechnology Stocks To ResearchDecember 8th - MarketBeat
Have Insiders Sold Clene Shares Recently? - simplywall.st
This Insider Has Just Sold Shares In Clene - 富途牛牛
Will Clene Inc. Equity Warrant stock beat EPS estimatesWeekly Profit Summary & High Accuracy Investment Signals - Улправда
Is Clene Inc. Equity Warrant stock attractive for retirement portfoliosWeekly Profit Report & AI Driven Stock Price Forecasts - Улправда
Why Clene Inc. stock remains on buy lists2025 Retail Activity & Stock Portfolio Risk Management - Улправда
Promising Nanotechnology Stocks To Follow TodayDecember 19th - MarketBeat
Published on: 2025-12-19 17:52:46 - Bölüm Sonu Canavarı
What technical signals suggest for Clene Inc. stockMarket Movers & Daily Chart Pattern Signals - Улправда
Will Clene Inc. stock gain from strong economyJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - DonanımHaber
Can Clene Inc. Equity Warrant stock weather global recessionJuly 2025 Earnings & Safe Capital Investment Plans - DonanımHaber
How Clene Inc. stock performs in weak economyWeekly Market Report & Free Reliable Trade Execution Plans - Улправда
Is Clene Inc. Equity Warrant stock dividend yield sustainable2025 Stock Rankings & Long Hold Capital Preservation Tips - DonanımHaber
Published on: 2025-12-19 10:58:32 - Улправда
[Form 4] Clene Inc. Insider Trading Activity - Stock Titan
Chidozie Ugwumba Sells 56,577 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Will Clene Inc. Equity Warrant stock return to pre crisis levelsJuly 2025 Summary & Safe Capital Growth Trade Ideas - Улправда
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 9,921 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 2,884 Shares - MarketBeat
Chidozie Ugwumba Sells 5,816 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Chidozie Ugwumba Sells 10,907 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Street Watch: Will Clene Inc. Equity Warrant stock beat EPS estimatesWeekly Earnings Recap & AI Based Trade Execution Alerts - ulpravda.ru
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 37,235 Shares - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 72,748 Shares of Stock - MarketBeat
Clene Insider Sold Shares Worth $1,725,735, According to a Recent SEC Filing - marketscreener.com
Owner Ugwumba Sells 257,795 ($1.7M) Of Clene Inc [CLNN] - TradingView — Track All Markets
Nanotechnology Stocks To ConsiderDecember 18th - MarketBeat
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):